Name | N-tert-butyl-3-[[5-methyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide |
---|---|
Synonyms |
3-[(5-Methyl-2-{[3-(4-morpholinylmethyl)phenyl]amino}-4-pyrimidinyl)amino]-N-(2-methyl-2-propanyl)benzenesulfonamide
Benzenesulfonamide, N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]- cc-107 EX-8666 RS0110 N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy - l)phenyl]amino]-4-pyrimidinyl]amino]benz |
Description | JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase[1]. |
---|---|
Related Catalog | |
References |
[1]. Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 686.9±65.0 °C at 760 mmHg |
Molecular Formula | C26H34N6O3S |
Molecular Weight | 510.65 |
Flash Point | 369.3±34.3 °C |
Exact Mass | 510.241302 |
PSA | 120.09000 |
LogP | 1.83 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.621 |
Hazard Codes | Xi |
---|